GuardCap Global Equity Fund X USD AccRegister to Unlock Ratings |
Performance History | 30/11/2019 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | 15.8 | 27.9 | 21.7 | 8.3 | 24.2 | |
+/-Cat | 9.6 | 7.6 | 4.7 | 13.1 | - | |
+/-B’mrk | - | - | - | - | - | |
Category: Global Large-Cap Growth Equity | ||||||
Category Benchmark: Morningstar Gbl Growth TME ... |
Key Stats | ||
NAV 28/11/2019 | USD 20.19 | |
Day Change | -0.27% | |
Morningstar Category™ | Global Large-Cap Growth Equity | |
ISIN | IE00BT6SQC49 | |
Fund Size (Mil) 20/11/2024 | USD 3601.17 | |
Share Class Size (Mil) 28/11/2019 | USD 12.85 | |
Max Initial Charge | - | |
Ongoing Charge 19/02/2024 | 0.09% |
Investment Objective: GuardCap Global Equity Fund X USD Acc |
The investment objective of the Fund is to seek long-term growth of capital with lower than market volatility by investing primarily in equity and similar securities issued by high quality companies listed on Recognised Markets in countries which are members of the Organisation for Economic Co-operation and Development (“OECD”). |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Michael Boyd 10/12/2014 | ||
Giles Warren 10/12/2014 | ||
Click here to see others | ||
Inception Date 10/12/2014 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
MSCI World NR EUR | Morningstar Gbl Growth TME NR USD |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for GuardCap Global Equity Fund X USD Acc | 31/08/2024 |
|
|
Top 5 Holdings | Sector | % |
CME Group Inc Class A | Financial Services | 6.52 |
Essilorluxottica | Healthcare | 5.92 |
Novo Nordisk A/S Class B | Healthcare | 5.57 |
Novonesis AS Class B | Basic Materials | 5.40 |
Alphabet Inc Class A | Communication Services | 5.05 |
Increase Decrease New since last portfolio | ||
GuardCap Global Equity Fund X USD Acc |